DIGITAL PATIENT IDENTIFICATION & SELECTION

Business services, namely, determination of patient eligibility for selection, participation and/or inclusion in clinical trials based upon specific inclusion and exclusion criteria for pharmaceutical companies, academic institutions, private companies and/or individuals that are using novel molecules to determine efficacy, effectiveness and/or safety